SU348210A1 - MEDICINE - Google Patents
MEDICINEInfo
- Publication number
- SU348210A1 SU348210A1 SU120581A SU120581A SU348210A1 SU 348210 A1 SU348210 A1 SU 348210A1 SU 120581 A SU120581 A SU 120581A SU 120581 A SU120581 A SU 120581A SU 348210 A1 SU348210 A1 SU 348210A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- medicine
- skin
- treatment
- mucous membranes
- lesions
- Prior art date
Links
- 210000004400 Mucous Membrane Anatomy 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 4
- LRQIWRXCHWNNEA-UHFFFAOYSA-L 10-[dimethyl-[2-(5-methyl-2-propan-2-ylcyclohexyl)oxy-2-oxoethyl]azaniumyl]decyl-dimethyl-[2-(5-methyl-2-propan-2-ylcyclohexyl)oxy-2-oxoethyl]azanium;dichloride Chemical compound [Cl-].[Cl-].CC(C)C1CCC(C)CC1OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)OC1C(C(C)C)CCC(C)C1 LRQIWRXCHWNNEA-UHFFFAOYSA-L 0.000 description 3
- 229960003145 decamethoxine Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003902 lesions Effects 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N (1S,3R,4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,25R,27R,29R,32R,33R,35S,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14, Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infection Diseases 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Description
Изобретение относитс к медицине и касаетс лекарственных средств, иснользуемых дл лечени кандидамикозных поражений кожи и слизистых оболочек.This invention relates to medicine and relates to drugs used to treat candida for skin and mucous membranes.
Известно применение различных лекарственных средств дл лечени капдидамикозных поражений кожи и слизистых оболочек, например нистатина. Однако использование указанных средств не всегда эффективно.The use of various drugs for the treatment of capdidamic lesions of the skin and mucous membranes, such as nystatin, is known. However, the use of these funds is not always effective.
Дл лечени кандидамикозных поражений кожи и слизистых оболочек предлагаетс примен ть декаметоксин.Decamethoxin has been proposed for the treatment of candidaic lesions of the skin and mucous membranes.
Декаметоксин используют в виде 0,025%ного раствора в изотоническом растворе поваренной соли. Лечение таким раствором провод т в виде аппликаций или полосканием полости рта 1-2 раза в день по 10-15 мин. Выздоровление, как правило, наступает через 15-30 дней.Decamethoxin is used as a 0.025% solution in an isotonic saline solution. Treatment with this solution is carried out in the form of applications or rinsing the mouth 1-2 times a day for 10-15 minutes. Recovery usually occurs in 15-30 days.
Предмет изобретени Subject invention
Применение декаметоксина дл лечени кандидамикозных поражений кожи и слизистых оболочек в качестве противогрибкового и антимикробного средства.The use of decamethoxine for the treatment of candidiasis lesions of the skin and mucous membranes as antifungal and antimicrobial agent.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU348210A1 true SU348210A1 (en) |
Family
ID=
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5487884A (en) * | 1987-10-22 | 1996-01-30 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
| US5487886A (en) * | 1989-10-10 | 1996-01-30 | The Gillette Company | Amino acid β-lyase enzyme inhibitors as deodorants |
| US5648513A (en) * | 1993-09-09 | 1997-07-15 | Laney; Judith Wolfe | O-acyl serines |
| CN106794140A (en) * | 2014-05-30 | 2017-05-31 | 娜塔莉亚·米克拉维娜·德卡奇 | Pharmaceutical composition based on active material stablizing solution |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5487884A (en) * | 1987-10-22 | 1996-01-30 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
| US5487886A (en) * | 1989-10-10 | 1996-01-30 | The Gillette Company | Amino acid β-lyase enzyme inhibitors as deodorants |
| US5648513A (en) * | 1993-09-09 | 1997-07-15 | Laney; Judith Wolfe | O-acyl serines |
| CN106794140A (en) * | 2014-05-30 | 2017-05-31 | 娜塔莉亚·米克拉维娜·德卡奇 | Pharmaceutical composition based on active material stablizing solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69923987T2 (en) | SYNERGISTIC ANTIMICROBIAL, DERMATOLOGICAL AND OPHTHALMOLOGICAL PREPARATION CONTAINING A CHLORITE AND HYDROGEN PEROXIDE | |
| JPH06206825A (en) | Agent for treatment of dermatosis caused by trichophyton, eczema, etc., and agent for skin disinfection and activation | |
| WO2003009802A2 (en) | Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide | |
| Leyden et al. | Aluminum chloride in the treatment of symptomatic athlete's foot | |
| US6696041B2 (en) | Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use | |
| SU348210A1 (en) | MEDICINE | |
| Rodeheaver et al. | Pharmacokinetics of a new skin wound cleanser | |
| WO2017189792A1 (en) | Use of hypochlorous acid as a topical antimicrobial | |
| Langston et al. | Renal phycomycosis | |
| Stawarz-Janeczek et al. | Disinfectants used in stomatology and SARS-CoV-2 infection | |
| ROBINSON et al. | Tolnaftate, a potent topical antifungal agent | |
| Warthin et al. | The pathology of the skin lesions produced by mustard gas (dichlorethylsulphide) | |
| US20020114850A1 (en) | Therapeutic bath solution containing alkali metal hypohalite | |
| Cason | Report on three extensive industrial chemical burns | |
| Gundrum | Effect of the Newer Sulfanilamide Derivatives on the Nasal Mucosa of Rabbits: Preliminary Report | |
| Carmichael et al. | Drug points: Pancytopenia associated with vancomycin | |
| JP3120965B2 (en) | Athlete's foot medicine | |
| US4975273A (en) | Anti-perspirative remedy for treatment of sweaty feet and other skin areas | |
| DE685510C (en) | Process for the production of durable aqueous chlorophyll solutions for medical purposes | |
| RU2196590C1 (en) | Agent carbon-mercury hydrosulfate complex and method of treatment of infectious inflammatory sicknesses | |
| SU1114422A1 (en) | Antifungous agent | |
| WAY | FISH SLIME DISEASE. | |
| Hall et al. | ART. I.--Account of the Erysipclatous Fever, as it appeared in the northern section of Vermont and New Hampshire, in the years 1842-3. | |
| Stawarz-Janeczek et al. | Disinfectants Used in Stomatology and | |
| SU186635A1 (en) | METHOD OF TREATING MYCOTIC DISEASES OF THE SKIN |